Regulation: OK After All

Published on: 

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-04-01-2001, Volume 0, Issue 0

London-The National Institute of Clinical Excellence (NICE) has decided that Roche's Xenical (orlistat) should be available from the National Health Service for managing obesity and its related problems, but it should not be viewed as a slimming pill.